Beginning March 2016, businesses shipping between London Heathrow and Tel Aviv will benefit from a dedicated wide-body service from IAG Cargo. The carrier is due to replace its remaining Airbus A321 with wide-body Boeing 777-200s with focus on benefits for Israel’s time and temperature-sensitive pharmaceuticals sector.

The Boeing 777-200s will operate twice daily.

Customers will benefit from a daily lift of 29 tons, representing a net increase of 2,500 tons in the summer of 2016 versus the same time this year, an increase of 72 percent.

“Tel Aviv is a thriving business center and it’s also one of the most important regions for the manufacture of pharmaceuticals,” said Alan Dorling, global head of pharmaceuticals and life sciences at IAG Cargo. “Through the additional capacity delivered by the 777-200, we can now offer manufacturers in the region greater lift, helping them, as they look to grow their businesses.”

By connecting through IAG Cargo’s London GDP approved Heathrow hub, Israeli pharmaceutical companies will benefit from access to 106 constant climate approved destinations, including extensive connections to the high-growth pharmaceuticals markets of Latin America.